Small Molecules

Our in silico modeling and simulation solutions are extremely valuable for both Abbreviated New Drug Application (ANDA) and 505(b)(2) programs.

By using our computational methods, in silico modeling and simulation can help predict the behavior of a drug in the human body, identify potential safety concerns, and optimize dosing regimens. We help streamline the drug development process by reducing the need for costly and time-consuming clinical trials.

For ANDA programs, in silico modeling can be used to demonstrate bioequivalence to a reference product, while for 505(b)(2) programs, it can provide valuable information to support a new drug application. In both cases, in silico modeling and simulation can help bring safe and effective drugs to market much faster and more efficiently.

InSilicoMinds - Leverage our In Silico Solutions for Large Molecules Drug Development

Large Molecules

Modeling and simulation techniques have revolutionized the field of drug discovery and development, enabling researchers to gain a deeper understanding of the molecular mechanisms underlying disease and the action of potential therapeutics. In particular, these techniques have proven to be invaluable in the development of large molecules such as biologics, proteins, and peptides. By allowing researchers to visualize and manipulate the structure and function of these complex molecules, modeling and simulation techniques can help to optimize their performance and improve their safety and efficacy.

We have several different types of in silico techniques that can be used for large molecules, including molecular dynamics simulations, quantum mechanics calculations, and homology modeling. Each of these techniques has its own strengths and limitations, and the choice of technique will depend on the specific research question being addressed.